These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2444315)

  • 1. [Comparative study of 3 serum markers of primary liver cancer: ferritin, alpha-fetoprotein and alpha-fucosidase].
    Bourel M; Deugnier Y; Brissot P; Leray G; Le Gall JY
    Bull Acad Natl Med; 1987 Mar; 171(3):359-64. PubMed ID: 2444315
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnostic value of serum alpha-L-fucosidase in primary hepatic carcinoma].
    Ke JL
    Zhonghua Yi Xue Za Zhi; 1989 Mar; 69(3):153-5. PubMed ID: 2776057
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum alpha-L-fucosidase activity and tumor size in hepatocellular carcinoma.
    Takahashi H; Saibara T; Iwamura S; Tomita A; Maeda T; Onishi S; Yamamoto Y; Enzan H
    Hepatology; 1994 Jun; 19(6):1414-7. PubMed ID: 7514563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of the serum measurement of alpha-L-fucosidase in the diagnosis of hepatocarcinoma].
    López Vivancos J; Segura RM; Oliva G; Vives L; Pascual C; Vilaseca J
    Med Clin (Barc); 1989 Sep; 93(7):241-3. PubMed ID: 2478845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum alpha-L-fucosidase activity and early detection of hepatocellular carcinoma: a prospective study of patients with cirrhosis.
    Giardina MG; Matarazzo M; Morante R; Lucariello A; Varriale A; Guardasole V; De Marco G
    Cancer; 1998 Dec; 83(12):2468-74. PubMed ID: 9874450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The value of serum alpha-L-fucosidase activity in the diagnosis of primary liver cancer].
    Wei X; Wang S; Rui J
    Zhonghua Zhong Liu Za Zhi; 2000 Mar; 22(2):148-50. PubMed ID: 11776645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumor markers in focal and diffuse liver diseases].
    Kasatkin IuN; Ametov AS; Mit'kov VV; Sevast'ianov SI; Zarudin VV
    Med Radiol (Mosk); 1984 Apr; 29(4):39-43. PubMed ID: 6201693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum ferritin in hepatocellular carcinoma.
    Zhou XD; Stahlhut MW; Hann HL; London WT
    Hepatogastroenterology; 1988 Feb; 35(1):1-4. PubMed ID: 2452122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum alpha-L-fucosidase. A useful marker in the diagnosis of hepatocellular carcinoma.
    Giardina MG; Matarazzo M; Varriale A; Morante R; Napoli A; Martino R
    Cancer; 1992 Sep; 70(5):1044-8. PubMed ID: 1381268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biological markers in hepatocellular carcinoma].
    Deugnier Y; David V; Leray G; Blayau M; Le Gall JY
    Ann Biol Clin (Paris); 1988; 46(1):85-8. PubMed ID: 2455460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of serum ferritin determination for hepatocellular carcinoma.
    Nakano S; Kumada T; Sugiyama K; Watahiki H; Takeda I
    Am J Gastroenterol; 1984 Aug; 79(8):623-7. PubMed ID: 6205585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic significance of the determination of serum alpha-L-fucosidase in primary hepatocellular carcinoma].
    Yu ZW; Duan FL; Yang XW
    Zhonghua Nei Ke Za Zhi; 1989 Jul; 28(7):394-6, 442. PubMed ID: 2556248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum alpha-L-fucosidase: a new marker for the diagnosis of primary hepatic carcinoma?
    Deugnier Y; David V; Brissot P; Mabo P; Delamaire D; Messner M; Bourel M; Legall JY
    Hepatology; 1984; 4(5):889-92. PubMed ID: 6207091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-fetoprotein and hepatocellular carcinoma.
    Colli A; Fraquelli M; Conte D
    Am J Gastroenterol; 2006 Aug; 101(8):1939; author reply 1940-1. PubMed ID: 16928257
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serum levels of alpha fetoprotein (AFP), B-chorionic gonadotropin (BHCG), ferritin and prostatic acid phosphatase (PAP) in patients with cancer of the stomach].
    Bukowski J; Góźdź S; Słuszniak J; Słuszniak A; Korejba W; Zieliński A; Banasińska E
    Wiad Lek; 1988 Jul; 41(14):915-20. PubMed ID: 2467444
    [No Abstract]   [Full Text] [Related]  

  • 16. [Combined five tumor markers in detecting primary hepatic carcinoma].
    Ma J; Gong Q; Lin M; Xi Y; Wang M; Chen Z; Pei Z; Ma W
    Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):14-6. PubMed ID: 11831976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum ferritin in patients with hepatobiliary diseases (author's transl)].
    Uchiyama Y; Kanazawa S; Okuda K
    Rinsho Ketsueki; 1980 Aug; 21(8):1104-11. PubMed ID: 6160268
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum alpha-fetoprotein and hepatocellular carcinoma size.
    Piantino P; Fusaro A; Daziano E
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):131. PubMed ID: 2480412
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical evaluation of several tumor markers in the diagnosis of primary hepatic cancer].
    Shi X; Zhou Y; Xia L
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):437-9. PubMed ID: 10920938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of alpha-fetoprotein with some other tumour markers in Malaysians with hepatocellular carcinoma.
    Lopez JB; Balasegaram M; Timor J; Thambyrajah V
    Malays J Pathol; 1997 Jun; 19(1):53-8. PubMed ID: 10879242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.